Vivos Therapeutics, Inc. (VVOS)
NASDAQ
Vivos Therapeutics, Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 17.4M | 15.0M | 13.8M | 16.0M | 16.9M | 13.1M | 11.4M |
| Gross Profit | 10.5M | 9.0M | 8.3M | 10.0M | 12.6M | 10.4M | 8.7M |
| Profitability | |||||||
| Operating Income | -19.9M | -11.2M | -17.3M | -25.0M | -20.4M | -12.0M | -10.6M |
| EBITDA | — | — | — | — | — | — | — |
| Net Income | -21.2M | -11.1M | -13.6M | -23.8M | -20.3M | -12.1M | -10.8M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 10M | 5M | 1M | 1M | 23M | 18M | 12M |
Vivos Therapeutics, Inc. Income Statement — FAQ
Vivos Therapeutics, Inc. (VVOS) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VVOS's income statement history?
The chart and table above show Vivos Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.